PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers. (May 2017) - Vendrely, V.; Lemanski, C.; Le Prise, E.; Maillard, E.; Mirabel, X.; Lledo, G.; Dahan, L.; Adenis, A.; Paintaud, G.; Lecomte, T.; Levy-Piedbois, C.; Terrebonne, E.; et al.